OMSB Pediatrics (OEPEDS) study materials
OMSB Pediatrics (OEPEDS) study resources

New-Onset Type 1 Diabetes With Moderate Diabetic Ketoacidosis

OMSB Pediatrics (OEPEDS) · Put your knowledge to work in context.

All case studies

New-Onset Type 1 Diabetes With Moderate Diabetic Ketoacidosis

A 9-year-old boy weighing 32 kg is brought to the emergency department with 3 weeks of polyuria and polydipsia, 2 days of vomiting and abdominal pain, and increasing drowsiness. His heart rate is 125/min, blood pressure 95/60 mm Hg, respiratory rate 30/min with deep breathing, and capillary refill 3 seconds. Initial results are glucose 28 mmol/L, venous pH 7.12, pCO2 22 mmHg, bicarbonate 10 mmol/L, blood ketones 5.2 mmol/L, sodium 132 mmol/L, potassium 5.1 mmol/L, urea 8 mmol/L, and creatinine 70 µmol/L. He has passed urine in the department. The resident asks for the initial fluid and insulin orders, when to add dextrose, and what to do if he develops a headache and bradycardia during treatment.

1. Write the initial fluid and insulin plan for this child, including calculations and electrolyte replacement.

Read the worked answer

This is moderate diabetic ketoacidosis with dehydration and a pseudohyponatremia pattern. I would not give an insulin bolus. I would start with 10 mL/kg of 0.9% saline, which is 320 mL, over 30–60 minutes for volume expansion, then reassess perfusion and urine output. For ongoing rehydration, I would use maintenance plus deficit over 48 hours. Using the 4–2–1 rule, maintenance is 40 + 20 + 12 = 72 mL/hour. A 5% deficit is 1,600 mL, or about 33 mL/hour over 48 hours, so the total would be about 105 mL/hour of 0.9% saline with 40 mmol/L potassium chloride. I would start an insulin infusion at 0.05–0.1 units/kg/hour, which is 1.6–3.2 units/hour, after the initial fluid bolus. Potassium replacement is appropriate because the potassium is 5.1 mmol/L and he is passing urine, but I would withhold it if potassium falls below 3.5 mmol/L or urine output stops. The reasoning is that slow, steady rehydration and low-dose insulin reduce the risk of cerebral edema and rapid osmotic shifts.

2. When and how would you add dextrose, and how would you adjust the insulin infusion as glucose falls?

Read the worked answer

I would add dextrose when the bedside glucose falls to about 14 mmol/L, using 5% dextrose in 0.45% saline or a similar solution, and I would continue the insulin infusion. The insulin must not be stopped, because it is needed to switch off ketogenesis and correct the acidosis even after glucose normalizes. I would target a glucose of 8–12 mmol/L and adjust the dextrose concentration rather than rapidly reducing insulin. If glucose falls faster than expected, I would increase the dextrose concentration first. I would check glucose hourly, electrolytes and blood gas every 2–4 hours, and monitor neurological status, urine output, and fluid balance. The reasoning is that ketones and acidosis lag behind glucose correction; stopping insulin when glucose is normal can provoke rebound ketosis and prolong the DKA.

3. During treatment he develops a severe headache, bradycardia, and rising blood pressure. What is your immediate concern and management?

Read the worked answer

These are warning signs of cerebral edema, a life-threatening complication of pediatric DKA treatment. I would stop or reduce the fluid infusion rate, elevate the head of the bed, ensure the airway and oxygenation, and give mannitol 0.5–1 g/kg IV, which is 16–32 g for this child, over 10–15 minutes. If mannitol is unavailable or there is severe hyponatremia, I would use 3% hypertonic saline 2.5–5 mL/kg, about 80–160 mL, over 10–15 minutes. I would call critical care and arrange urgent neuroimaging only after stabilizing the airway and circulation, because treatment should not be delayed for imaging. I would avoid hypotonic fluids, check sodium and glucose, and slow the insulin if glucose is falling too quickly. The reasoning is that cerebral edema is driven by rapid osmotic shifts and fluid shifts during DKA correction, and early recognition with hyperosmolar therapy is the key to preventing herniation.